Skip to content
The Nexus
DossierENTITY

Marshall Fordyce

Coverage of Marshall Fordyce in the Nexus archive.

Earliest in view: Jul 7 · 16:44 UTCMost recent: Jul 7 · 16:44 UTC
Co-mentioned in this coverage
FDAorganization1Vera Therapeuticsorganization1Trutaknatopic1IgA nephropathytopic1
Recent coverage
  • HEALTHJul 7 · 16:44 UTCSTAT NEWS
    STAT+: FDA approves Vera Therapeutics kidney disease treatment

    The FDA approved Trutakna, a new treatment for IgA nephropathy, a chronic autoimmune kidney disease, developed by Vera Therapeutics. Vera CEO Marshall Fordyce expressed excitement about bringing the drug to patients.

Marshall Fordyce · Dossier · The Nexus